Discover 1,576 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,576
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
for
Macular Edema Secondary to Inflammation
Location: New York NY, Palisades Park NJ, Greenwich CT,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT06990399
Phase 3, Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
for
Macular Edema Secondary to Inflammation
Location: New York NY, Palisades Park NJ, Greenwich CT,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT06996080
Phase 3, Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
for
Acute Coronary Syndrome
Location: Staten Island NY, New York NY, Hackensack NJ,
Sponsor: DalCor Pharmaceuticals
Sex: All
Age: 45+
Code: NCT05918861
Phase 3, Recruiting
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
for
Esophageal Squamous Cell Carcinoma
Location: Brooklyn NY, Morristown NJ, Hershey PA, Fairfax VA,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06644781
Phase 3, Recruiting
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
for
Breast Neoplasms
Location: New York NY, The Bronx NY, Florham Park NJ,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07173751
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
for
Rhinovirus Infection
Location: Brooklyn NY, Hamilton NJ, Binghamton NY, Sayre PA,
Sponsor: Altesa Biosciences, Inc.
Sex: All
Age: 40 - 70+
Code: NCT07610395
Phase 2, Recruiting
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
for
Cardiovascular Disease
Location: Brooklyn NY, New York NY, The Bronx NY, Laurelton NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07000357
Phase 3, Recruiting
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
for
Major Depressive Disorder
Location: New York NY, Brooklyn NY, Toms River NJ,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 18 - 65
Code: NCT05850689
Phase 3, Recruiting
Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
for
Major Depressive Disorder (MDD)
Location: New York NY, Brooklyn NY, Marlton NJ, Cromwell CT,
Sponsor: Supernus Pharmaceuticals, Inc.
Sex: All
Age: 18 - 70
Code: NCT07226661
Phase 2, Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
for
Overweight, Obesity
Location: Long Island City NY, Warren Township NJ, Eatontown NJ,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07282600
Phase 3, Recruiting
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
for
HER2-positive Gastric Cancer,
Location: New York NY, Summit NJ, Albany NY, Silver Spring MD,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06764875
Phase 3, Recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
for
Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma,
Location: New York NY, Hackensack NJ, New Brunswick NJ,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06564038
Phase 1, Phase 2, Recruiting
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
for
B-cell Malignancies
Location: New York NY, Hackensack NJ, Montreal, Toronto,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06542250
Phase 1, Phase 2, Recruiting
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis